Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2019. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3763537013 | Product containing precisely nicotine (as nicotine polacrilex) 2 milligram/1 each conventional release oromucosal lozenge (clinical drug) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 3763538015 | Nicotine (as nicotine polacrilex) 2 mg oromucosal lozenge | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely nicotine (as nicotine polacrilex) 2 milligram/1 each conventional release oromucosal lozenge (clinical drug) | Is a | Nicotine lozenges | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely nicotine (as nicotine polacrilex) 2 milligram/1 each conventional release oromucosal lozenge (clinical drug) | Has active ingredient | Nicotine | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely nicotine (as nicotine polacrilex) 2 milligram/1 each conventional release oromucosal lozenge (clinical drug) | Has manufactured dose form | Oromucosal AND/OR gingival dosage form | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely nicotine (as nicotine polacrilex) 2 milligram/1 each conventional release oromucosal lozenge (clinical drug) | Has manufactured dose form | Conventional release oromucosal lozenge | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely nicotine (as nicotine polacrilex) 2 milligram/1 each conventional release oromucosal lozenge (clinical drug) | Has manufactured dose form | Oropharyngeal dose form | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely nicotine (as nicotine polacrilex) 2 milligram/1 each conventional release oromucosal lozenge (clinical drug) | Is a | TEMPORARY parent for CDs that are not updated | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely nicotine (as nicotine polacrilex) 2 milligram/1 each conventional release oromucosal lozenge (clinical drug) | Is a | Product containing only nicotine in oromucosal dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely nicotine (as nicotine polacrilex) 2 milligram/1 each conventional release oromucosal lozenge (clinical drug) | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely nicotine (as nicotine polacrilex) 2 milligram/1 each conventional release oromucosal lozenge (clinical drug) | Has basis of strength substance | Nicotine | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely nicotine (as nicotine polacrilex) 2 milligram/1 each conventional release oromucosal lozenge (clinical drug) | Has precise active ingredient | Nicotine polacrilex | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely nicotine (as nicotine polacrilex) 2 milligram/1 each conventional release oromucosal lozenge (clinical drug) | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely nicotine (as nicotine polacrilex) 2 milligram/1 each conventional release oromucosal lozenge (clinical drug) | Has presentation strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely nicotine (as nicotine polacrilex) 2 milligram/1 each conventional release oromucosal lozenge (clinical drug) | Has presentation strength denominator unit | Lozenge | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely nicotine (as nicotine polacrilex) 2 milligram/1 each conventional release oromucosal lozenge (clinical drug) | Has presentation strength numerator value | 2 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely nicotine (as nicotine polacrilex) 2 milligram/1 each conventional release oromucosal lozenge (clinical drug) | Has unit of presentation | Lozenge | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| NiQuitin CQ 2mg original lozenge | Is a | False | Product containing precisely nicotine (as nicotine polacrilex) 2 milligram/1 each conventional release oromucosal lozenge (clinical drug) | Inferred relationship | Existential restriction modifier | |
| NiQuitin CQ 2mg mint lozenge | Is a | False | Product containing precisely nicotine (as nicotine polacrilex) 2 milligram/1 each conventional release oromucosal lozenge (clinical drug) | Inferred relationship | Existential restriction modifier | |
| Nicotinell 2mg mint lozenge | Is a | False | Product containing precisely nicotine (as nicotine polacrilex) 2 milligram/1 each conventional release oromucosal lozenge (clinical drug) | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR